Biogen Releases New Data Showing Effectiveness of Tecfidera in Newly Diagnosed MS Patients at AAN 2016

Stuart SchlossmanMS Drug Therapies, Multiple Sclerosis, Oral MS Medications

                                                                  


Click here to receive MS news via e-mail        

 

Biogen reported
new data describing the effectiveness of Tecfidera (dimethyl fumarate) in
newly diagnosed relapsing-remitting multiple sclerosis (RRMS) patients in a
recent presentation at the 68th annual meeting of the American Academy of
Neurology (AAN). The conference, taking place in Vancouver, Canada, runs
through April 21. Tecfidera is an oral medication taken twice
daily. Although the biological activity of […]


Read on »


~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
MS Views and News
Provides educational information, resources and services for those affected by MS
We Believe YOU (the MS Patients and Caregivers) should Be Empowered with Multiple Sclerosis information
.===================================





Visit our MS Learning Channel on YouTube: http://www.youtube.com/msviewsandnews